PositiveID seeks patent for iGlucose system
DELRAY BEACH, Fla. PositiveID has filed nonprovisional patent application for its iGlucose system with the U.S. Patent and Trademark Office.
The iGlucose system uses wireless SMS messaging to automatically communicate a diabetic patient’s blood glucose levels from any data-capable glucose meter to an online database. PositiveID said the system is designed to automatically communicate with a wide variety of glucometers by utilizing electronics and stored information that will query and recognize a particular glucometer when connected to the device. The program
Scott R. Silverman, chairman and CEO of PositiveID, said, “We are pleased to file this patent application to protect the key technology underlying the iGlucose System. We believe iGlucose has the potential to revolutionize the way diabetics and their healthcare providers manage this widespread disease through more effective and consistent communication of blood sugar levels.”
Study: Selenium may cut men’s risk of diabetes
NEW YORK A recent study published in BioMed Central’s open access journal, Nutrition and Metabolism, has shown that men with a higher concentration of selenium in their bodies are less likely to develop diabetes.
Tasnime Akbaraly, from the University of Montpellier, worked with a team of researchers to follow 1,162 healthy French men and women for nine years, monitoring plasma selenium concentrations and incidence of dysglycemia. Akbaraly said during the study period, 127 new cases of dysglycemia occurred, of which 70 were in men and 57 in women. She pointed out, however, that elderly men with high plasma selenium concentrations were “significantly associated with a lower risk of developing dysglycemia over the following nine years.”
“The reason we observed a protective effect of selenium in men but not in women is not completely clear, but might be attributed to women being healthier at baseline, having better antioxidant status in general and possible differences in how men and women process selenium,” Akbaraly said.
Selenium, a trace mineral that is an essential element in several metabolic pathways and is found in such foods as walnuts and various types of fish.
Alison Sweeney becomes spokeswoman for Zyrtec product
FORT WASHINGTON, Pa. “The Biggest Loser” and “Days of Our Lives” star Alison Sweeney will join McNeil Consumer Healthcare as the face of the new Zyrtec Liquid Gels, the company announced Friday.
Sweeney participated in a race in New York to officially welcome the first day of spring. The “Race Against Your Allergies” took place in New York City’s Madison Square Park.
“I’ve partnered with the makers of Zyrtec Liquid Gels as a fun way to kick off the season and show fellow allergy sufferers and lovers of the outdoors how we can outrun our allergy symptoms this year,” Sweeney said.
“We’re excited to be providing allergy sufferers with the opportunity to participate in a fun activity to welcome the first day of spring, while learning how to manage and relieve the everyday allergy symptoms the season can bring,” said Rohinish Hooda, VP marketing, upper respiratory for McNeil Consumer Healthcare.